Form 4 for PCRX Pacira BioSciences, Inc.
Accepted 2024-08-13 00:00:00 ET · period of report 2024-08-12 · accession 0001396814-24-000112 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-08-13 | 2024-08-12 | PCRX | Lee Frank D. | CEO, Dir | P - Purchase | $12.10 | +8,264 | 107.8K | +8% | +$100.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-08-12 | P | A | 8,264 | $12.10 | 107,784 | D | — | — |